期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Background Glioma is one of the most aggressive malignant brain tumors that is characterized with inevitably infiltrative growth and poor prognosis. A......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Background Recent studies have investigated the role of circular RNAs (circRNAs) as significant regulatory factors in multiple cancer progression. Nev......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Background Reprogrammed glucose metabolism, also known as the Warburg effect, which is essential for tumor progression, is regarded as a hallmark of c......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Background: Liver cancer stem cells (LCSCs) play key roles in the metastasis, recurrence, and chemotherapeutic resistance of hepatocellular carcinoma ......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Background Glioma is the most common and malignant tumor of central nervous system. The tumor initiation, self-renewal, and multi-lineage differentiat......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Background Among the common preventable cancers of women, cervical cancer has the highest morbidity. It is curable if detected at an early stage. Howe......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Background Serotonin signaling has been associated with tumorigenesis and tumor progression. Targeting the serotonin transporter to block serotonin ce......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, with poor prognosis and limited treatment options. Hy......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Although hepatocellular carcinoma (HCC) is one of the deadliest health burdens worldwide, few drugs are available for its clinical treatment. However,......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Background High-risk neuroblastoma patients have a 5-year survival rate of less than 50%. It's an urgent need to identify new therapeutic targets and ......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
The recent discovery of immune checkpoint inhibitors is a significant milestone in cancer immunotherapy research. However, some patients with primary ......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Background Osteosarcoma (OS) is the most common primary bone cancer in adolescents and lung metastasis is the leading cause of death in patients with ......
期刊： JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021; 40 (1)
Primary liver cancer (PLC) is a common malignancy with high morbidity and mortality. Poor prognosis and easy recurrence on PLC patients calls for opti......
